ΕΚΤΕΛΕΣΤΙΚΟΣ ΚΑΝΟΝΙΣΜΟΣ (ΕΕ) αριθ. 710/2014 ΤΗΣ ΕΠΙΤΡΟΠΗΣ της 23ης Ιουνίου 2014 για τον καθορισμό εκτελεστικών τεχνικών προτύπων όσον αφορά τις συνθήκες εφαρμογής της διαδικασίας κοινής απόφασης για τις εποπτικές απαιτήσεις ανά ίδρυμα, σύμφωνα με την οδηγία 2013/36/ΕΕ του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου (Κείμενο που παρουσιάζει ενδιαφέρον για τον ΕΟΧ)
ΕΚΤΕΛΕΣΤΙΚΟΣ ΚΑΝΟΝΙΣΜΟΣ (ΕΕ) αριθ. 710/2014 ΤΗΣ ΕΠΙΤΡΟΠΗΣ
της 23ης Ιουνίου 2014
για τον καθορισμό εκτελεστικών τεχνικών προτύπων όσον αφορά τις συνθήκες εφαρμογής της διαδικασίας κοινής απόφασης για τις εποπτικές απαιτήσεις ανά ίδρυμα, σύμφωνα με την οδηγία 2013/36/ΕΕ του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου
Έχοντας υπόψη τη Συνθήκη για τη λειτουργία της Ευρωπαϊκής Ένωσης,
Έχοντας υπόψη την οδηγία 2013/36/ΕΕ του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου, της 26ης Ιουνίου 2013, σχετικά με την πρόσβαση στη δραστηριότητα πιστωτικών ιδρυμάτων και την προληπτική εποπτεία πιστωτικών ιδρυμάτων και επιχειρήσεων επενδύσεων, για την τροποποίηση της οδηγίας 2002/87/ΕΚ και για την κατάργηση των οδηγιών 2006/48/ΕΚ και 2006/49/ΕΚ (1), και ιδίως το άρθρο 113 παράγραφος 5 τρίτο εδάφιο,
Εκτιμώντας τα ακόλουθα:
(1)
Η αποτελεσματική ανταλλαγή κατάλληλων πληροφοριών είναι απαραίτητη για την επίτευξη κοινής απόφασης σχετικά με την επάρκεια των ιδίων κεφαλαίων, τα εποπτικά μέτρα που αφορούν την εποπτεία ρευστότητας, το ύψος της ρευστότητας και των κεφαλαιακών απαιτήσεων που ισχύουν για κάθε ίδρυμα εντός ενός ομίλου και για τον όμιλο.
(2)
Προκειμένου να εξασφαλιστεί συνεπής εφαρμογή της διαδικασίας για την επίτευξη κοινής απόφασης, είναι σημαντικό να είναι σαφώς καθορισμένο το κάθε στάδιο. Η καθιέρωση σαφούς διαδικασίας διευκολύνει επίσης την ανταλλαγή πληροφοριών, προωθεί την αμοιβαία κατανόηση, αναπτύσσει τις σχέσεις μεταξύ των εποπτικών αρχών και προωθεί την αποτελεσματική εποπτεία.
(3)
Προκειμένου να προβεί στην αξιολόγηση κινδύνων και στην αξιολόγηση του προφίλ κινδύνου ρευστότητας ενός ομίλου ιδρυμάτων, η αρχή ενοποιημένης εποπτείας θα πρέπει να έχει μια γενική εικόνα των δραστηριοτήτων που αναπτύσσουν όλα τα ιδρύματα εντός του ομίλου, συμπεριλαμβανομένων των ιδρυμάτων που λειτουργούν εκτός της Ένωσης. Θα πρέπει, επομένως, να προωθηθεί η αλληλεπίδραση μεταξύ των αρμοδίων αρχών στην Ένωση και των εποπτικών αρχών τρίτων χωρών, προκειμένου οι πρώτες να είναι σε θέση να αξιολογήσουν τους παγκόσμιους κινδύνους που αντιμετωπίζει ο όμιλος.
(4)
Είναι απαραίτητος ο έγκαιρος και ρεαλιστικός προγραμματισμός της διαδικασίας λήψης κοινής απόφασης. Κάθε εμπλεκόμενη αρμόδια αρχή θα πρέπει να παρέχει στην αρχή ενοποιημένης εποπτείας τις σχετικές πληροφορίες εγκαίρως. Προκειμένου οι εξατομικευμένες αξιολογήσεις να παρουσιάζονται και να ερμηνεύονται κατά συνεπή και ομοιόμορφο τρόπο, είναι αναγκαίο να καθιερωθεί κοινό υπόδειγμα για τα αποτελέσματα των διαδικασιών εποπτικής εξέτασης και αξιολόγησης για κάθε συγκεκριμένο ίδρυμα.
(5)
Για τη διασφάλιση ομοιόμορφων συνθηκών εφαρμογής της διαδικασίας κοινής απόφασης, θα πρέπει να καθοριστούν τα στάδια που πρέπει να ακολουθούνται για την πραγματοποίηση της κοινής αξιολόγησης κινδύνων και την επίτευξη της κοινής απόφασης, αναγνωρίζοντας ότι ορισμένες εργασίες της κοινής αξιολόγησης κινδύνων και της διαδικασίας λήψης κοινών αποφάσεων μπορούν να πραγματοποιούνται παράλληλα και άλλες διαδοχικά.
(6)
Για να διευκολυνθεί η επίτευξη κοινών αποφάσεων, είναι σημαντικό οι αρμόδιες αρχές που συμμετέχουν στη διαδικασία λήψης αποφάσεων να συνδιαλέγονται μεταξύ τους, ιδίως πριν από την οριστικοποίηση των εκθέσεων αξιολόγησης των κινδύνων και των κοινών αποφάσεων.
(7)
Η αρχή ενοποιημένης εποπτείας θα πρέπει να παρέχει στις εμπλεκόμενες αρμόδιες αρχές όλες τις σχετικές πληροφορίες που είναι αναγκαίες για την προετοιμασία της επιμέρους αξιολόγησης του κινδύνου από τις αρχές αυτές, καθώς και για να καταστεί δυνατή η επίτευξη κοινών αποφάσεων σχετικά με τα κεφάλαια και τη ρευστότητα.
(8)
Η έκθεση που περιλαμβάνει την αξιολόγηση των κινδύνων του ομίλου αποτελεί βασικό έγγραφο, το οποίο επιτρέπει στις αρμόδιες αρχές να κατανοήσουν και να καταγράψουν την αξιολόγηση του συνολικού προφίλ κινδύνου του τραπεζικού ομίλου, με σκοπό την επίτευξη μιας κοινής απόφασης σχετικά με την επάρκεια των ιδίων κεφαλαίων και το επίπεδο των ιδίων κεφαλαίων που οφείλει να διατηρεί ο όμιλος. Η έκθεση που περιλαμβάνει την αξιολόγηση του προφίλ κινδύνου ρευστότητας του ομίλου αποτελεί σημαντικό έγγραφο, το οποίο επιτρέπει στις αρμόδιες αρχές να κατανοήσουν και να καταγράψουν την αξιολόγηση του συνολικού προφίλ ρευστότητας του ομίλου. Για την παρουσίαση της συνολικής αξιολόγησης κινδύνου και της αξιολόγησης κινδύνου ρευστότητας του ομίλου με συνεπή τρόπο, τη διεξαγωγή ουσιαστικών συζητήσεων μεταξύ των αρμοδίων αρχών και την αξιόπιστη αξιολόγηση των κινδύνων των διασυνοριακών τραπεζικών ομίλων, θα πρέπει να καθιερωθούν κοινά υποδείγματα για τις εν λόγω εκθέσεις.
(9)
Αναγνωρίζοντας ότι τα αποτελέσματα της διαδικασίας εποπτικής εξέτασης και αξιολόγησης, που αναφέρεται στο άρθρο 97 της οδηγίας 2013/36/ΕΕ, μπορούν να τεκμηριωθούν με διαφορετικό τρόπο στα διάφορα κράτη μέλη, ανάλογα με την εφαρμογή του εν λόγω άρθρου στην εθνική νομοθεσία, λαμβάνοντας παράλληλα υπόψη τις κατευθυντήριες γραμμές που εκδίδονται από την Ευρωπαϊκή Εποπτική Αρχή (Ευρωπαϊκή Αρχή Τραπεζών) (ΕΑΤ), σύμφωνα με το άρθρο 107 παράγραφος 2 της οδηγίας 2013/36/ΕΕ, τα τυποποιημένα υποδείγματα θα πρέπει να παρέχουν συνεπή μορφότυπα για την ανακοίνωση των πορισμάτων και των αποτελεσμάτων της διαδικασίας εποπτικής αξιολόγησης, για τους σκοπούς της επίτευξης κοινών αποφάσεων.
(10)
Ούτε η έκθεση αξιολόγησης των κινδύνων του ομίλου, ούτε η έκθεση που περιλαμβάνει την αξιολόγηση κινδύνου ρευστότητας του ομίλου θα πρέπει να περιορίζεται στη συγκέντρωση των επιμέρους εισηγήσεων των αρμοδίων αρχών. Αμφότερες οι εκθέσεις θα πρέπει να χρησιμοποιούνται ως εργαλείο για τη διενέργεια της κοινής αξιολόγησης των κινδύνων ολόκληρου του ομίλου και για την ανάλυση της αλληλεπίδρασης μεταξύ των ενδοομιλικών στοιχείων.
(11)
Η καθιέρωση σαφών διαδικασιών για το περιεχόμενο και τη διατύπωση κοινών αποφάσεων θα πρέπει να διασφαλίζει ότι οι κοινές αποφάσεις είναι πλήρως αιτιολογημένες, καθώς και ότι διευκολύνουν τον έλεγχο των κοινών αποφάσεων και της επιβολής τους.
(12)
Προκειμένου να αποσαφηνιστεί η διαδικασία που πρέπει να ακολουθείται μόλις επιτευχθεί η κοινή απόφαση, να εξασφαλιστεί διαφάνεια ως προς τη διαχείριση του αποτελέσματος της απόφασης και να διευκολυνθούν οι επακόλουθες ενέργειες, όπου χρειάζεται, θα πρέπει να καθοριστούν πρότυπα όσον αφορά τη γνωστοποίηση της πλήρως αιτιολογημένης κοινής απόφασης και τον έλεγχο της εφαρμογής της.
(13)
Θα πρέπει να καθοριστεί η διαδικασία που θα ακολουθείται για την προσαρμογή των κοινών αποφάσεων στα πρόσφατα δεδομένα, προκειμένου να εξασφαλιστεί συνεπής και διαφανής προσέγγιση, καθώς και κατάλληλη συμμετοχή των αρμοδίων αρχών και γνωστοποίηση των αποτελεσμάτων.
(14)
Η κοινή διαδικασία λήψης αποφάσεων σύμφωνα με το άρθρο 113 της οδηγίας 2013/36/ΕΕ περιλαμβάνει τη διαδικασία που πρέπει να ακολουθείται σε περίπτωση που δεν ληφθεί κοινή απόφαση. Για να διασφαλιστούν ομοιόμορφες συνθήκες εφαρμογής της συγκεκριμένης πτυχής της διαδικασίας, καθώς και η διατύπωση πλήρως αιτιολογημένων αποφάσεων και η αποσαφήνιση του τρόπου αντιμετώπισης τυχόν απόψεων και επιφυλάξεων των εποπτικών αρχών υποδοχής, θα πρέπει να καθοριστούν πρότυπα που να καλύπτουν το χρονοδιάγραμμα για τη λήψη αποφάσεων ελλείψει κοινής απόφασης, καθώς και τη γνωστοποίηση των λεπτομερειών των εν λόγω αποφάσεων.
(15)
Ο παρών κανονισμός βασίζεται στο σχέδιο εκτελεστικών τεχνικών προτύπων που υπέβαλε η ΕΑΤ στην Επιτροπή.
(16)
Η ΕΑΤ διεξήγαγε ανοικτές δημόσιες διαβουλεύσεις όσον αφορά τα σχέδια εκτελεστικών τεχνικών προτύπων στα οποία βασίζεται ο παρών κανονισμός, προέβη σε ανάλυση του δυνητικού σχετικού κόστους/οφέλους και ζήτησε τη γνώμη της ομάδας τραπεζικών συμφεροντούχων, που συστάθηκε σύμφωνα με το άρθρο 37 του κανονισμού (ΕΕ) αριθ. 1093/2010 του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου (2)·
ΕΞΕΔΩΣΕ ΤΟΝ ΠΑΡΟΝΤΑ ΚΑΝΟΝΙΣΜΟ:
Ο παρών κανονισμός είναι δεσμευτικός ως προς όλα τα μέρη του και ισχύει άμεσα σε κάθε κράτος μέλος.
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (million EUR) at reference date:
Competent authority:
Overall SREP assessment
Overall SREP score (following the capital and liquidity adequacy assessment):
This section should contain a summary of the assessments made in the sections below.
Capital adequacy assessment
Within this section please provide: (1) a summary of the assessment of the capital adequacy; (2) the preliminary proposal for the joint decision, including a statement on the adequacy of own funds at the respective entity level and any required level of own funds in excess of the requirements set out in Chapter Four of Title VII of Directive 2013/36/EU (CRD) and in Regulation (EU) No 575/2013 (CRR); (3) the outlook for next assessment period; and, (4) a description of any other capital-related supervisory measures (1).
Within this section please also describe how SREP capital estimates have been derived and how ICAAP capital estimates have been taken into account, if assessed as reliable.
Liquidity Adequacy Assessment
Within this section please provide: (1) a summary of the assessment of the liquidity adequacy; (2) the proposal for the joint decision, including a statement on the adequacy of liquidity at the respective entity level and any required supervisory measures, where applicable; (3) the outlook for the next assessment period; and, (4) a description of any other supervisory measures to address the deficiencies identified, where applicable.
Depending on the timing of the joint decision on liquidity, this assessment should either mirror the findings summarised in the Liquidity SREP report (see template in Annex 5), or provide an updated assessment.
A. Business model analysis (viability and sustainability)
Score:
Within this section please provide: (1) a description of the evolution of the business model, strategy and financial position within the observed period; (2) the supervisory assessment of the viability of the current business model and sustainability of the strategy; and, (3) any relevant supervisory measures, including capital and non-capital supervisory measures.
B. Internal governance arrangements
Score:
Within this section please provide: (1) a description of the evolution of the internal governance framework within the observed period; (2) deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to internal governance requirements; (4) the outlook for the next assessment period; (5) actions to be taken by the institution, and, (6) any relevant supervisory measures, including capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C. Risks to solvency
C.1 Credit and counterparty risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.2 Settlement/delivery risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.3 Inter-concentration risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.5 IRRBB
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.6 Operational risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.7 Risk of excessive leverage
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.8 Other risks material to the institution, as applicable (please specify)
Score:
Within this section please provide: (1) a description of the evolution of other identified risks to solvency in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Within this section please provide: (1) a description of the evolution of liquidity and funding risks in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Depending on the timing of the joint decision on liquidity, this assessment should either mirror the findings summarised in the Liquidity SREP report (see template in Annex 5), or provide an updated assessment.
Should the assessment of liquidity and funding risks highlight significant issues in relation to funding risk requiring the allocation of capital to mitigate impacts from an increased cost of funding, please describe how it is reflected in the additional own funds requirements, if relevant.
E. Systemic risk
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) the outlook for the next assessment period; and, (3) any supervisory measures, including capital and non-capital supervisory measures.
F. ICAAP review
Within this section please provide: (1) a summary of the findings of the assessment of the reliability of the ICAAP framework and institution’s own quantification of risks and the consequent allocation of appropriate internal capital; (2) a description of the evolution of ICAAP framework in the observed period; (3) deficiencies identified; (4) issues of non-compliance with the CRR and the CRD in relation to the ICAAP; (5) mitigating actions to be taken by the institution; and (6) any relevant supervisory measures, including capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
The section should also have a statement on whether ICAAP estimates are considered reliable and could serve as an input into the assessment of capital adequacy.
G. Inter-risk diversification effects
Taking into account the outcome of the ICAAP assessments and internal capital estimates, and only in case diversification effects are recognised, please provide within this section a description of the impact of diversification effects and define the extent to which benefits from the diversification effects can be taken into account in the determination of capital adequacy.
Within this section please summarise the results and their impact on capital adequacy of institutions own stress tests and their reconciliation with supervisory stress tests, including the explanation of how the stress testing buffer was derived, where applicable.
Other relevant information
Within this section please provide other information deemed relevant by the competent authority for the purposes of the group risk assessment and not provided above.
Quantitative Indicators agreed by the consolidating supervisor and the host EEA competent authorities (pursuant to RTS/ITS on colleges of supervisors)
Please list any quantitative indicators agreed to be shared while developing the joint risk assessment report for the purposes of reaching a joint decision.
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (mln EUR) at reference date:
Competent authority:
SREP elements
Score
A.
Business Model (viability and sustainability)
B.
Internal governance arrangements
C.
Risks to solvency
C.1
Credit and counterparty risk
C.2
Settlement / Delivery risk
C.3
Inter-concentration risk
C.4
Market risk
C.5
IRRBB
C.6
Operational risk
C.7
Risk of excessive leverage
C.8
Other risks material to the institution, as applicable (please specify)
C.9
Other risks material to the institution, as applicable (please specify)
D.
Risks to liquidity
[as per the outcome of the Liquidity SREP report]
These scores should be consistent with the respective assessments under the liquidity joint decision. Depending on the timing of the joint decision on liquidity, this assessment should either mirror the findings summarised in the liquidity SREP report, or provide updated assessment.
E.
Systemic risk (risk that institution poses to financial system)
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (mln EUR) at reference date:
Competent authority:
SREP elements
Memoranda items
Overall SREP capital requirement/estimate (including supervisory proxy, where applicable) (in mln EUR)
Pillar 1 capital requirements, where applicable (in mln EUR)
ICAAP estimate (in mln EUR)
A.
Business Model (viability and sustainability)
B.
Internal governance arrangements
C.
Risks to solvency (risks and controls)
C.1
Credit and counterparty risk
C.2
Settlement / Delivery risk
C.3
Inter-concentration risk
C.4
Market risk
C.5
IRRBB
C.6
Operational risk
C.7
Risk of excessive leverage
C.8
Other risks material to the institution, as applicable (please specify)
C.9
Other risks material to the institution, as applicable (please specify)
D.
Risks to liquidity — Funding risk (cost of funding perspective)
E.
Systemic risk (risk that institution poses to financial system)
F.
Inter-risk diversification effects
G.
Capital planning / stress test buffer (where applicable)
Capital planning / Stress testing buffer based on the outcomes of ICAAP stress tests, where applicable
Reconciliation of ICAAP stress tests with supervisory stress tests and resulting capital planning / stress testing buffer, where applicable
SREP capital outcome (preliminary proposal for joint decision discussion)
Overall capital requirement/estimate
Total Pillar 1 capital requirement
Total ICAAP capital estimate
Total SREP capital estimate
Capital adequacy assessment (capital is assessed as adequate/inadequate)
Adequate/Inadequate
Additional own funds requirement
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Memoranda items (values at reference date)
Total own funds (mln EUR) at reference date
Tier 1 own funds (mln EUR) at reference date
Common Equity Tier 1 own funds (mln EUR) at reference date
Total risk weighted assets (mln EUR) at reference date
The own funds requirements applicable in the home Member State in accordance with Article 92 of Regulation (EU) No 575/2013, taking into account any measures adopted or recognised in accordance with Article 458 of that Regulation and the transitional arrangements laid down in Part X of that Regulation
The level of the capital conservation buffer that the institution is required to maintain in accordance with Article 129 of Directive 2013/36/EU
The level of the institution-specific countercyclical capital buffer to be maintained by the institution in accordance with Article 130 of Directive 2013/36/EU
The level of any systemic risk buffer that the institution is required to maintain in accordance with Article 133 of Directive 2013/36/EU
The level of any G-SII buffer or O-SII buffer that the institution is required to maintain in accordance with Article 128(3) and (4) of Directive 2013/36/EU
Any other prudential requirements applicable to the institution, including under Article 103 of Directive 2013/36/EU, macro-prudential measures and recommendations of EBA and ESRB
The Group risk assessment report shall include as annexes all SREP reports submitted by the relevant competent authorities. The group risk assessment report shall be supplemented with summaries of scores (Table 1) and the capital adequacy assessment (Table 2).
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (million EUR) at reference date:
Overall SREP assessment of the Group
Overall SREP score (following the capital and liquidity adequacy assessment):
This section should contain a summary of the assessments made in the sections below,
Capital adequacy assessment
Within this section please provide: (1) a summary of the assessment of the capital adequacy; (2) the proposal for the joint decision, including a statement on the adequacy of own funds at the group level and any required level of own funds in excess of the requirements set out in Chapter Four of Title VII of Directive 2013/36/EU (CRD) and in Regulation (EU) No 575/2013 (CRR); (3) the outlook for the next assessment period; and, (3) a description of any other capital-related supervisory measures (1).
Within this section please also describe how SREP capital estimates have been derived and how ICAAP capital estimates have been taken into account, if assessed as reliable.
Liquidity Adequacy Assessment
Within this section please provide: (1) a summary of the assessment of the liquidity adequacy; (2) the proposal for the joint decision, including a statement on the adequacy of liquidity at the group level and any required supervisory measures, where applicable; (3) the outlook for the next assessment period; and, (4) a description of any other supervisory measures to address the deficiencies identified, where applicable.
Depending on the timing of the joint decision on liquidity, this assessment should either mirror the findings summarised in the Group liquidity risk assessment report (see template in Annex 7), or provide an updated assessment.
A. Business model analysis (viability and sustainability)
Score:
Within this section please provide: (1) a description of the evolution of the business model, strategy and financial position within the observed period; (2) the supervisory assessment of the viability of the current business model and sustainability of the strategy; and, (3) any relevant supervisory measures, including capital and non-capital supervisory measures.
B. Internal governance arrangements
Score:
Within this section please provide: (1) a description of the evolution of the internal governance framework within the observed period; (2) deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to internal governance requirements; (4) the outlook for the next assessment period; (5) actions to be taken by the institution, and, (6) any relevant supervisory measures, including capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C. Risks to solvency
C.1 Credit and counterparty risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.2 Settlement/delivery risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.3 Inter-concentration risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.5 IRRBB
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.6 Operational risk
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.7 Risk of excessive leverage
Score:
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
C.8 Other risks material to the institution, as applicable (please specify)
Score:
Within this section please provide: (1) a description of the evolution of other identified risks to solvency in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Within this section please provide: (1) a description of the evolution of liquidity and funding risks in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures including, capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
Depending on the timing of the joint decision on liquidity, this assessment should either mirror the findings summarised in the Group liquidity risk assessment report (see template in Annex 7), or provide an updated assessment.
Should the assessment of liquidity and funding risks highlight significant issues in relation to funding risk requiring the allocation of capital to mitigate impacts from an increased cost of funding, please describe how it is reflected in the additional own funds requirements, if relevant.
E. Systemic risk
Within this section please provide: (1) a description of the evolution of the risk in the observed period; (2) the outlook for the next assessment period; and, (3) any supervisory measures, including capital and non-capital supervisory measures.
F. ICAAP review
Within this section please provide: (1) a summary of the findings of the assessment of the reliability of the ICAAP framework and institution’s own quantification of risks and the consequent allocation of appropriate internal capital; (2) a description of the evolution of ICAAP framework in the observed period; (3) deficiencies identified; (4) issues of non-compliance with the CRR and the CRD in relation to the ICAAP; (5) mitigating actions to be taken by the institution; and (6) any relevant supervisory measures, including capital and non-capital supervisory measures to address the deficiencies and non-compliance issues.
The section should also have a statement on whether ICAAP estimates are considered reliable and could serve as an input into the assessment of capital adequacy.
G. Inter-risk diversification effects
Taking into account the outcome of the ICAAP assessments and internal capital estimates, and only in case diversification effects are recognised, please provide within this section a description of the impact of diversification effects and define the extent to which benefits from the diversification effects can be taken into account in the determination of capital adequacy.
Within this section please summarise the results and their impact on capital adequacy of institutions own stress tests and their reconciliation with supervisory stress tests, including the explanation of how the stress testing buffer was derived, where applicable.
Other relevant information
Within this section please provide other information deemed relevant by the competent authorities for the purposes of the group risk assessment and not provided above (e.g. information needed to meet requirements of Article 6(5) of this Implementing Regulation.
Quantitative Indicators agreed by the consolidating supervisor and the host EEA competent authorities (pursuant to RTS/ITS on colleges of supervisors)
Please list any quantitative indicators agreed to be shared while developing the joint risk assessment report for the purposes of reaching a joint decision.
SREP capital outcome (preliminary proposal for joint decision discussion)
Overall capital requirement/estimate
Total Pillar 1 capital requirement
Total ICAAP capital estimate
Total SREP capital estimate
Total Pillar 1 capital requirement
Total ICAAP capital estimate
Total SREP capital estimate
Total Pillar 1 capital requirement
Total ICAAP capital estimate
Total SREP capital estimate
Capital adequacy assessment (capital is assessed as adequate/inadequate)
Adequate/Inadequate
Adequate/Inadequate
Adequate/Inadequate
Additional own funds requirement
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
I.
Diversification effects, including intra-group (-)
Intra-group concentration (+)
Intra-group support arrangements (-)
Other intra-group items (+/-)
J.
Joint decision outcome (based on preliminary proposal (H), reflecting impact of intra-group items, and results of the dialogue between competent authorities)
Overall capital requirement/estimate
Total SREP capital estimate
Total SREP capital estimate
Total SREP capital estimate
Capital adequacy assessment (capital is assessed as adequate/inadequate)
Adequate/Inadequate
Adequate/Inadequate
Adequate/Inadequate
Additional own funds requirement
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Sum of components or holistic approach (formulated as an amount or ratio, or combination of both)
Common Equity Tier 1 own funds (mln EUR) at reference date
Total risk weighted assets (mln EUR) at reference date
The own funds requirements applicable in the home Member State in accordance with Article 92 of Regulation (EU) No 575/2013 taking into account any measures adopted or recognised under Article 458 of that Regulation and the transitional arrangements under Part X of that Regulation
The level of the capital conservation buffer required to be maintained by the institution in accordance with Article 129 of Directive 2013/36/EU
The level of the institution-specific countercyclical capital buffer to be maintained by the institution in accordance with Article 130 of Directive 2013/36/EU
The level of the systemic risk buffer to be maintained by the institution, if applicable, in accordance with Article 133 of Directive 2013/36/EU
The level of the any G-SII buffer or O-SII buffer, as defined in paragraphs (3) and (4) respectively of Article 128 of Directive 2013/36/EU, to be held by the institution
Any other prudential requirements applicable to the institution, including under Article 103 of Directive 2013/36/EU, macro-prudential measures and recommendations of EBA and ESRB
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (million EUR) at reference date:
Competent authority:
Overall Assessment of Liquidity Risk in SREP
Overall liquidity risk Score :
This section should contain a summary of the individual assessments below.
Liquidity Adequacy Assessment
Within this section please provide: (1) a summary of the assessment of the liquidity adequacy; (2) the proposal for the joint decision, including a statement on the adequacy of liquidity at the respective entity level and any supervisory measures, where applicable, to address significant matters and material findings; and, (3) the outlook for the next assessment period.
A. Assessment of liquidity risk
Score:
Within this section please provide: (1) a description of the evolution of liquidity risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
B. Assessment of funding risk
Score:
Within this section please provide: (1) a description of the evolution of funding risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
C. Assessment of liquidity and funding risk management
Score:
Within this section please provide: (1) a description of the evolution of liquidity and funding risk management in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
Other relevant information
Within this section please provide other information deemed relevant by the competent authority for the purposes of the group risk assessment and not provided above.
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (mln EUR) at reference date:
Competent authority:
Liquidity elements in SREP
Outcome of liquidity risk assessment
(in mln euros or ratio or narrative information on measures)
A.
Liquidity adequacy assessment
Adequate/Inadequate
B.
Proposal for joint decision - Quantitative measures (Articles 104 and 105)
Specific liquidity buffer requirements [To be specified in terms of LCR eligible assets post-introduction of LCR as a standard (optional before)]
Specific stable funding requirements [To be specified on NSFR definition post-NSFR introduced as a standard (optional before)]
Other quantitative restrictions/requirements
D
Proposal for joint decision — Qualitative measures (Articles 104 and 105)
Memoranda items (values at reference date)
Actual LCR ratio or any other equivalent domestic ratio (until LCR implementation in CRR)
Actual NSFR ratio or any other equivalent domestic ratio (until NSFR implementation in CRR)
LCR buffer requirement, if any ('Pillar 1')
NSFR stable funding requirement, if any ('Pillar 1')
Any other prudential requirements applicable to the institution, including under Article 103 of Directive 2013/36/EU, macro-prudential measures and recommendations of EBA and ESRB
The Group liquidity risk assessment report includes as annexes all liquidity risk assessment reports submitted by the relevant competent authorities. The group risk assessment report is supplemented with summaries of scores (Table 1) and liquidity adequacy assessment (Table 2).
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (million EUR) at reference date:
Overall Assessment of Liquidity Risk in SREP
Overall liquidity risk Score :
This section should contain a summary of the individual assessments below.
Liquidity Adequacy Assessment
Within this section please provide: (1) a summary of the assessment of the liquidity adequacy; (2) the proposal for the joint decision, including a statement on the adequacy of liquidity at the group level and any supervisory measures, where applicable, to address significant matters and material findings; and, (3) the outlook for the next assessment period.
A. Assessment of liquidity risk
Score:
Within this section please provide: (1) a description of the evolution of liquidity risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
B. Assessment of funding risk
Score:
Within this section please provide: (1) a description of the evolution of funding risk in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
C. Assessment of liquidity and funding risk management
Score:
Within this section please provide: (1) a description of the evolution of liquidity and funding risk management in the observed period; (2) control deficiencies identified; (3) issues of non-compliance with the CRR and the CRD in relation to risk; (4) the outlook for the next assessment period; (5) risk mitigating actions to be taken by the institution; and, (6) any relevant supervisory measures to address the deficiencies and non-compliance issues.
Other relevant information
Within this section please provide other information deemed relevant by the competent authorities for the purposes of the group risk assessment and not provided above (e.g. information needed to meet requirements of Article 6(5) of this Implementing Regulation
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
[based on national classification until common categorisation approach is in place as per EBA Guidelines for common SREP methodologies and procedures; the category to which the institution is assigned shall reflect also its systemic importance]
Reference date:
Total assets (mln EUR) at reference date:
Competent authority:
Liquidity elements in SREP
Outcome of liquidity risk assessment
Outcome of liquidity risk assessment
Outcome of liquidity risk assessment
(in mln Euros or ratio or narrative information on measures]
(in mln Euros or ratio or narrative information on measures]
(in mln Euros or ratio or narrative information on measures]
A.
Liquidity adequacy assessment
Adequate/Inadequate
Adequate/Inadequate
Adequate/Inadequate
B.
Proposal for joint decision - Quantitative measures (Articles 104 and 105)
Specific liquidity buffer requirements [To be specified in terms of LCR eligible assets post-introduction of LCR as a standard (optional before)]
Specific stable funding requirements [To be specified on NSFR definition post-NSFR introduced as a standard (optional before)]
Other quantitative restrictions/requirements
D
Proposal for joint decision — Qualitative measures (Articles 104 and 105)
Actual LCR ratio or any other equivalent domestic ratio (until LCR implementation in CRR)
Actual NSFR ratio or any other equivalent domestic ratio (until NSFR implementation in CRR)
LCR buffer requirement, if any ('Pillar 1')
NSFR stable funding requirement, if any ('Pillar 1')
Any other prudential requirements applicable to the institution, including under Article 103 of Directive 2013/36/EU, macro-prudential measures and recommendations of EBA and ESRB
